Keyphrases
Strong Impact
100%
Acute Coronary Syndrome
100%
Antiplatelet
100%
Peripheral Arterial Disease
100%
Cardiovascular Outcomes
100%
MACCE
18%
At Discharge
18%
Diabetic
9%
Clinical Treatment
9%
Target Vessel Revascularization
9%
Revascularization
9%
Clinical Characteristics
9%
Cardiovascular Risk
9%
Randomized Clinical Trial
9%
Clinical Presentation
9%
Hypertensive
9%
Dual Antiplatelet Therapy
9%
Treatment Decisions
9%
Follow-up Time
9%
Cardiovascular Mortality
9%
Undertreated
9%
Event-free Survival
9%
Cardiovascular Therapy
9%
Optimal Medical Therapy
9%
Multicenter Registry
9%
Acute Treatment
9%
Real-life Setting
9%
Adverse Cardiovascular Events
9%
New Cardiovascular Events
9%
Cardiovascular and Cerebrovascular Diseases
9%
Intermittent Claudication
9%
Major Haemorrhage
9%
Arterial Ischemic Events
9%
Non-peripheral
9%
Medicine and Dentistry
Cardiovascular System
100%
Antiplatelet
100%
Arteriosclerosis Obliterans
100%
Acute Coronary Syndrome
100%
Apoplexy
18%
Transient Ischemic Attack
18%
Target Vessel Revascularization
9%
Combination Therapy
9%
Bleeding
9%
Revascularization
9%
Cardiovascular Risk
9%
Randomized Clinical Trial
9%
Event Free Survival
9%
Nonaqueous Capillary Electrophoresis
9%
Intermittent Claudication
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Antiplatelet
100%
Peripheral Occlusive Artery Disease
100%
Cerebrovascular Accident
18%
Transient Ischemic Attack
18%
Combination Therapy
9%
Bleeding
9%
Cardiovascular Risk
9%
Randomized Clinical Trial
9%
Event Free Survival
9%
Intermittent Claudication
9%
Nursing and Health Professions
Acute Coronary Syndrome
100%
Peripheral Occlusive Artery Disease
100%
Transient Ischemic Attack
18%
Cerebrovascular Accident
18%
Revascularization
9%
Combination Therapy
9%
Cardiovascular Risk
9%
Bleeding
9%
Target Vessel Revascularization
9%
Dual Antiplatelet Therapy
9%
Event Free Survival
9%
Nonaqueous Capillary Electrophoresis
9%
Intermittent Claudication
9%
Immunology and Microbiology
Revascularization
100%
Event Free Survival
100%
Target Vessel Revascularization
100%
Biochemistry, Genetics and Molecular Biology
Event Free Survival
100%
Randomized Clinical Trial
100%